Tower Research Capital (TRC)’s Aterian ATER Stock Holding History
Bought
Maintained
Sold
Other funds holding ATER
XT
VCM
VFT
Tower Research Capital (TRC)'s ATER Position: Q1 2026 in Review
Tower Research Capital (TRC) reduced its Aterian (ATER) stake by 0.54% in Q1 2026, selling an estimated $5 and leaving 1,466 shares worth $840. The position accounts for ﹤0.01% of the portfolio, ranked #4768.
Tower Research Capital (TRC) first reported a position in ATER in Q3 2019 and has held it in 27 quarters since. The position peaked at $93K in Q1 2021. 26 funds tracked by Wall St. Rank hold ATER as of Q1 2026.
- Tower Research Capital (TRC) held 1,466 shares of Aterian worth $840 as of Q1 2026.
- Tower Research Capital (TRC) sold 8 Aterian shares in Q1 2026, an estimated $5.
- Aterian made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4768 holding.
- Tower Research Capital (TRC) first reported a position in Aterian in Q3 2019 and has held it in 27 quarters since.
- Tower Research Capital (TRC)'s Aterian position peaked at $93K in Q1 2021.
- 26 funds tracked by Wall St. Rank held Aterian as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.